[1]
“HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome”, UTJsci, vol. 5, no. 3, pp. 48–56, May 2019, Accessed: May 01, 2024. [Online]. Available: https://jsci.utq.edu.iq/index.php/main/article/view/138